hat is passed on to the customer.???A stricter regulatory landscape over products that go into APIs (active pharmaceutical ingredients) has also been a strain on margins, he added.A welcome changeHowever, despite the fact Evonik is the world???s third largest producer of amino acids ??? used in treatments such as high blood pressure and diabetes ??? Hermann believes the industry will not feel a he